Suppr超能文献

[组织型纤溶酶原激活剂和链激酶制剂对肺动脉血栓栓塞症患者的溶栓治疗]

[Fibrinolytic therapy of patients with pulmonary artery thromboembolism by tissue plasminogen activator and streptokinase preparations].

作者信息

Ardashev V N, Sokolianskiĭ N V, Bystrov V V

出版信息

Klin Med (Mosk). 2000;78(12):28-30.

Abstract

Changes in clinical and hemodynamic indices, hemostatic system during therapy with plasminogen tissue activator and streptokinase drugs were studied in 49 patients with massive and submassive forms of pulmonary thromboembolism. Conduction of fibrinolytic therapy with plasminogen tissue activator vs streptokinase produced more marked and rapid change in the main hemodynamic parameters which characterized blood recovery in pulmonary artery. A correlation was revealed between the change in hemostatic system after thrombolytic therapy and development of hemorrhagic complications. Preferable introduction of plasminogen tissue activator is shown when thromboemboli locate in the trunk or in both main pulmonary arteries and in the presence of an occlusive lesion in lobular arteries.

摘要

对49例大面积和次大面积肺血栓栓塞症患者,研究了在使用组织型纤溶酶原激活剂和链激酶药物治疗期间临床和血流动力学指标、止血系统的变化。与链激酶相比,使用组织型纤溶酶原激活剂进行纤溶治疗时,主要血流动力学参数的变化更显著、更迅速,这些参数表征了肺动脉血流的恢复。溶栓治疗后止血系统的变化与出血并发症的发生之间存在相关性。当血栓栓子位于主干或双侧主肺动脉,以及小叶动脉存在闭塞性病变时,显示优先使用组织型纤溶酶原激活剂。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验